Compare Bio Protocol (BIO) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Mitosis — how do they compare? Bio Protocol trades at Rp515.76 (market cap Rp1,16T, Rp252,63M 24h volume), while Mitosis trades at Rp390.2 (market cap Rp70,8M, Rp81,24M 24h volume). The key difference: Bio Protocol is far larger — about 16384.2× Mitosis's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Mitosis for 19 Days on average.
| BIO | MITO | |
|---|---|---|
Market Cap | Rp1,16T | Rp70,8M |
Volume (24h) | Rp252,63M | Rp81,24M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 16 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mitosis (MITO) is currently trading at Rp387.21 with a market cap of Rp70.55 million, showing a bearish technical signal amid low circulation at 19%. The token hovers near support at Rp382, with neutral oscillators but weak moving averages. Recent news highlights a corporate acquisition of a similarly named entity, but no direct crypto ecosystem updates are noted.
Overall outlook remains cautious due to bearish momentum and limited liquidity. Key opportunities include potential rebounds from support levels, while major risks involve low adoption, high volatility, and regulatory uncertainties in the crypto space.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
